These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 1984797

  • 1. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
    van Marwijk Kooy M, van Prooijen HC, Moes M, Bosma-Stants I, Akkerman JW.
    Blood; 1991 Jan 01; 77(1):201-5. PubMed ID: 1984797
    [Abstract] [Full Text] [Related]

  • 2. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
    Sintnicolaas K, van Marwijk Kooij M, van Prooijen HC, van Dijk BA, van Putten WL, Claas FH, Novotny VM, Brand A.
    Blood; 1995 Feb 01; 85(3):824-8. PubMed ID: 7833483
    [Abstract] [Full Text] [Related]

  • 3. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
    Oksanen K, Kekomäki R, Ruutu T, Koskimies S, Myllylä G.
    Transfusion; 1991 Sep 01; 31(7):588-94. PubMed ID: 1891788
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
    Sniecinski I, O'Donnell MR, Nowicki B, Hill LR.
    Blood; 1988 May 01; 71(5):1402-7. PubMed ID: 3282572
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical aspects of platelet transfusions.
    Murphy MF, Waters AH.
    Blood Coagul Fibrinolysis; 1991 Apr 01; 2(2):389-96. PubMed ID: 1893071
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia.
    Schiffer CA, Dutcher JP, Aisner J, Hogge D, Wiernik PH, Reilly JP.
    Blood; 1983 Oct 01; 62(4):815-20. PubMed ID: 6349715
    [Abstract] [Full Text] [Related]

  • 14. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study.
    Novotny VM, van Doorn R, Witvliet MD, Claas FH, Brand A.
    Blood; 1995 Apr 01; 85(7):1736-41. PubMed ID: 7703481
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial.
    van de Watering L, Hermans J, Witvliet M, Versteegh M, Brand A.
    Transfusion; 2003 Jun 01; 43(6):765-71. PubMed ID: 12757528
    [Abstract] [Full Text] [Related]

  • 20. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC.
    J Surg Res; 2020 Nov 01; 255():99-105. PubMed ID: 32543385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.